Pfizer's (NYSE: PFE) share price has fallen more than the S&P 500 so far this year. If you're a growth investor, you probably ...

By most standards, Pfizer looks like the proverbial knife in the investing ... such as cancer therapies Adcetris and Padcev along with migraine drug Nurtec ODT, that should help offset the revenue ...

Zacks Investment Research Image Source: Zacks Investment Research Presently, Pfizer looks like a discounted stock ... Pfizer's growth is boosted by Nurtec ODT, acquired from Biohaven and Padcev ...

Income investors should especially like Pfizer because ... with migraine drug Nurtec ODT, that should help offset the revenue declines. In addition, Pfizer's pipeline looks promising with 115 ...

We recently published a list of 11 Best Innovative Stocks to Buy According to Analysts. In this article, we are going to take a look at where Pfizer Inc.

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Even if it's not a dominant player in the market, having a solid asset like pemvidutide could lead ... the sell-off looks way overdone. Moderna isn't just a "pandemic stock": It could deliver ...

Eliquis saw 10% global growth, while Nurtec recorded a 36% increase in global ... The market is currently under the lead of competitors like Novo Nordisk and Eli Lilly. So for danu, just to ...